Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1987 1
1991 1
1993 1
2002 3
2003 3
2004 1
2005 3
2007 4
2008 6
2009 2
2010 3
2011 4
2012 3
2013 2
2014 7
2015 6
2016 7
2017 7
2018 6
2019 4
2020 3
2021 7
2022 4
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
Bradley JD, Hu C, Komaki RR, Masters GA, Blumenschein GR, Schild SE, Bogart JA, Forster KM, Magliocco AM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Koprowski CD, Olson MR, Meng J, Paulus R, Curran WJ Jr, Choy H. Bradley JD, et al. Among authors: olson mr. J Clin Oncol. 2020 Mar 1;38(7):706-714. doi: 10.1200/JCO.19.01162. Epub 2019 Dec 16. J Clin Oncol. 2020. PMID: 31841363 Free PMC article. Clinical Trial.
TH9 immunodeficiency in patients with hyper-IgE syndrome.
Olson MR, Kaplan MH. Olson MR, et al. J Allergy Clin Immunol. 2019 Mar;143(3):935-936. doi: 10.1016/j.jaci.2018.10.044. Epub 2018 Nov 12. J Allergy Clin Immunol. 2019. PMID: 30439405 Free article. No abstract available.
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.
Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, Zhang CJ, Nichols EM, Malik N, Gregory R, Bantscheff M, Ghidelli-Disse S, Kolev M, Frum T, Spence JR, Sexton JZ, Alysandratos KD, Kotton DN, Pittaluga S, Bibby J, Niyonzima N, Olson MR, Kordasti S, Portilla D, Wobus CE, Laurence A, Lionakis MS, Kemper C, Afzali B, Kazemian M. Yan B, et al. Among authors: olson mr. Sci Immunol. 2021 Apr 7;6(58):eabg0833. doi: 10.1126/sciimmunol.abg0833. Sci Immunol. 2021. PMID: 33827897 Free PMC article.
Tox induces T cell IL-10 production in a BATF-dependent manner.
Canaria DA, Rodriguez JA, Wang L, Yeo FJ, Yan B, Wang M, Campbell C, Kazemian M, Olson MR. Canaria DA, et al. Among authors: olson mr. Front Immunol. 2023 Nov 20;14:1275423. doi: 10.3389/fimmu.2023.1275423. eCollection 2023. Front Immunol. 2023. PMID: 38054003 Free PMC article.
Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
Imam T, Park S, Kaplan MH, Olson MR. Imam T, et al. Among authors: olson mr. Front Immunol. 2018 Jun 1;9:1212. doi: 10.3389/fimmu.2018.01212. eCollection 2018. Front Immunol. 2018. PMID: 29910812 Free PMC article. Review.
The development and in vivo function of T helper 9 cells.
Kaplan MH, Hufford MM, Olson MR. Kaplan MH, et al. Among authors: olson mr. Nat Rev Immunol. 2015 May;15(5):295-307. doi: 10.1038/nri3824. Epub 2015 Apr 7. Nat Rev Immunol. 2015. PMID: 25848755 Free PMC article. Review.
STAT3 Activation Impairs the Stability of Th9 Cells.
Ulrich BJ, Verdan FF, McKenzie AN, Kaplan MH, Olson MR. Ulrich BJ, et al. Among authors: olson mr. J Immunol. 2017 Mar 15;198(6):2302-2309. doi: 10.4049/jimmunol.1601624. Epub 2017 Jan 30. J Immunol. 2017. PMID: 28137893 Free PMC article.
84 results